Entecavir
Baraclude (entecavir) is a small molecule pharmaceutical. Entecavir was first approved as Baraclude on 2005-03-29. It is used to treat chronic hepatitis b and hepatitis b in the USA. It has been approved in Europe to treat chronic hepatitis b and hepatitis b.
| Trade Name | Baraclude |
|---|---|
| Common Name | Entecavir |
| Indication | chronic hepatitis b, hepatitis b |
| Drug Class | Antivirals: carbocyclic nucleosides |
